Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pamela DiPiro, M.D.

Concepts (192)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Referral and Consultation5202335790.920 Why?
Oncology Service, Hospital22017570.680 Why?
Carcinoma, Lobular220204880.600 Why?
Abdominal Neoplasms120192860.570 Why?
Physician Assistants120181880.520 Why?
Breast Neoplasms182023209920.520 Why?
Mammography12201824240.500 Why?
Radiology4202321010.440 Why?
Neoplasms, Second Primary2201910510.430 Why?
Fibrocystic Breast Disease520001030.420 Why?
Tomography, X-Ray Computed132023204990.410 Why?
Biopsy, Needle8200016270.370 Why?
Academic Medical Centers5202327420.360 Why?
Lymphoma, Large B-Cell, Diffuse2201714020.320 Why?
Breast8200019610.310 Why?
Cancer Care Facilities220184190.290 Why?
Radiology Information Systems320215280.290 Why?
Inflammatory Breast Neoplasms220201460.290 Why?
Lymphoma, T-Cell120093040.280 Why?
Medical Oncology1201823080.270 Why?
Liver Neoplasms2202043140.270 Why?
Neoplasm Metastasis3201648860.250 Why?
Evidence-Based Medicine1201736700.250 Why?
Radiology Department, Hospital220194050.220 Why?
Ultrasonography, Mammary520182390.210 Why?
Magnetic Resonance Imaging72021362700.210 Why?
Genes, erbB-2220141620.200 Why?
Carcinoma, Ductal, Breast5202010960.190 Why?
Stereotaxic Techniques520005490.190 Why?
Fluorodeoxyglucose F182202020040.180 Why?
Forms and Records Control120201580.160 Why?
Incidental Findings220206930.150 Why?
Calcinosis5200014670.150 Why?
Multiple Pulmonary Nodules120201670.150 Why?
Calcium Phosphates120181710.140 Why?
Surgical Instruments119993820.140 Why?
Solitary Pulmonary Nodule120202700.140 Why?
Workload120028450.140 Why?
Retrospective Studies182023799840.140 Why?
Environment1200211170.140 Why?
Tumor Burden2201418860.140 Why?
Lung Neoplasms62020132680.130 Why?
Neoplasms52017219860.130 Why?
Quality Improvement3202037930.130 Why?
Foreign Bodies119993970.120 Why?
Immunoconjugates120239490.120 Why?
Seat Belts11995600.120 Why?
Humans5020237575660.120 Why?
Patient Care Planning120209060.120 Why?
Positron-Emission Tomography4201764570.120 Why?
Neoplasm Recurrence, Local4201792450.120 Why?
Receptors, Progesterone2202011290.120 Why?
Female3720233899430.110 Why?
Terminology as Topic1202015330.100 Why?
Clinical Protocols1201814360.100 Why?
Radiopharmaceuticals2202026340.100 Why?
Carcinoma, Intraductal, Noninfiltrating119999350.100 Why?
Receptor, erbB-23202325520.100 Why?
Receptors, Estrogen2202022080.090 Why?
Genes, BRCA1120147650.090 Why?
Interprofessional Relations120179890.090 Why?
Mucous Membrane120136570.090 Why?
Quinazolines2201413710.090 Why?
Breast Diseases319984430.090 Why?
Immunoblastic Lymphadenopathy12009400.080 Why?
Pleural Neoplasms120146090.080 Why?
Prognosis42019294880.080 Why?
Accidents, Traffic119958150.080 Why?
Survival Analysis22019100750.080 Why?
Contrast Media3201852970.080 Why?
Leukemia-Lymphoma, Adult T-Cell120091640.080 Why?
Neoplasm Staging72020110820.080 Why?
Pulmonary Embolism2201225400.080 Why?
Middle Aged2520202191920.080 Why?
Delivery of Health Care, Integrated120169320.070 Why?
Aged2120201678900.070 Why?
Lymphoma, Large-Cell, Anaplastic120091670.070 Why?
Follow-Up Studies62020390200.070 Why?
Nose Neoplasms120092490.070 Why?
Decision Support Techniques1201719910.070 Why?
Hodgkin Disease1201413770.070 Why?
Patient-Centered Care1201714150.070 Why?
Cone-Beam Computed Tomography120104710.070 Why?
Central Nervous System Neoplasms120149160.070 Why?
Adult2120202197250.060 Why?
Molecular Targeted Therapy1201727960.060 Why?
Melanoma2201456890.060 Why?
Diabetes Mellitus, Type 11199934320.060 Why?
Uterine Cervical Neoplasms1201620060.060 Why?
Carcinoma, Non-Small-Cell Lung2201452720.060 Why?
Carcinoma in Situ220007930.060 Why?
Aged, 80 and over92019585580.050 Why?
Antineoplastic Combined Chemotherapy Protocols22014117090.050 Why?
Radiation Injuries1201011840.050 Why?
Boston3201992980.050 Why?
Brachytherapy1201012240.050 Why?
Mass Screening1201854120.050 Why?
Physicians1202045770.050 Why?
Bone Neoplasms1201425240.050 Why?
Iohexol220142040.050 Why?
Radiography2202369560.050 Why?
Brain Neoplasms1202389810.050 Why?
Diagnosis, Differential32020129510.050 Why?
Camptothecin120235890.040 Why?
Gastrointestinal Stromal Tumors120056150.040 Why?
Antineoplastic Agents32017135970.040 Why?
Medical Record Linkage120192860.040 Why?
Workflow120228500.040 Why?
Radiographic Image Enhancement220148750.040 Why?
Treatment Outcome72023642420.040 Why?
Ultrasonography, Interventional2200214870.040 Why?
Negotiating120181480.040 Why?
Carcinoma, Squamous Cell1201240190.030 Why?
Radiographic Magnification11996190.030 Why?
Male1120173581800.030 Why?
Fibroadenoma11996410.030 Why?
Axilla120186260.030 Why?
Comprehensive Health Care120161230.030 Why?
Fat Necrosis11995600.030 Why?
Adenocarcinoma1201263230.030 Why?
Contusions11995790.030 Why?
Risk2201895900.030 Why?
Piperazines1200525110.030 Why?
Radiography, Interventional2199911120.030 Why?
Evaluation Studies as Topic1199616280.030 Why?
Data Collection1200233190.030 Why?
Pyrimidines1200530050.030 Why?
Antibodies, Neoplasm120142810.030 Why?
Models, Organizational120165460.030 Why?
Lymph Node Excision1201812770.030 Why?
Cysts119976810.020 Why?
Vinblastine120134880.020 Why?
Kaplan-Meier Estimate2201264700.020 Why?
Markov Chains120149650.020 Why?
Maytansine12011860.020 Why?
Radiotherapy, Adjuvant1199617880.020 Why?
Mastectomy, Segmental119969720.020 Why?
Biopsy2199967570.020 Why?
Mastectomy1201818340.020 Why?
Chemotherapy, Adjuvant1201835100.020 Why?
Ultrasonography2200059510.020 Why?
Skin Neoplasms1200957980.020 Why?
Estrogen Replacement Therapy1199612060.020 Why?
Vacuum22000650.020 Why?
Lymphocytes, Tumor-Infiltrating1201410870.020 Why?
Neoadjuvant Therapy1201828090.020 Why?
Life Expectancy1201412380.020 Why?
Risk Factors12014737080.020 Why?
Prospective Studies22023540920.020 Why?
Statistics, Nonparametric1201228470.020 Why?
Angiogenesis Inhibitors1201720470.020 Why?
Drug Administration Schedule1201448450.020 Why?
Lymphatic Metastasis1201329140.020 Why?
Radiation Dosage1201419570.020 Why?
Massachusetts1201888150.020 Why?
Cohort Studies22023411900.020 Why?
Decision Making1201839090.010 Why?
Observer Variation1201025990.010 Why?
Survivors1201423700.010 Why?
Neovascularization, Pathologic1201426380.010 Why?
Time Factors21996398110.010 Why?
Outpatients1201115900.010 Why?
Lymph Nodes1199334700.010 Why?
Dose-Response Relationship, Drug12014107490.010 Why?
Diagnostic Imaging1201635240.010 Why?
Cross-Sectional Studies12002259240.010 Why?
Cost-Benefit Analysis1201454830.010 Why?
Sex Factors12014104950.010 Why?
Biomedical Research1201634150.010 Why?
Recurrence1201284260.010 Why?
Early Detection of Cancer1201431640.010 Why?
Venous Thromboembolism1201218470.010 Why?
Benzamides1200513630.010 Why?
Multivariate Analysis12012120470.010 Why?
Automation120005810.010 Why?
Protein Kinase Inhibitors1201456380.010 Why?
Age Factors12014183260.010 Why?
Smoking1201490360.010 Why?
Hyperplasia1200011530.010 Why?
Image Processing, Computer-Assisted1201489460.010 Why?
Imaging, Three-Dimensional1201040460.010 Why?
Antibodies, Monoclonal1201491630.010 Why?
Anticoagulants1201247770.010 Why?
Reproducibility of Results12014200370.010 Why?
Chi-Square Distribution1200034150.010 Why?
Incidence12011212170.010 Why?
Equipment Design1200035020.010 Why?
Neoplasm Invasiveness1200035910.010 Why?
Lung1201099730.010 Why?
Young Adult12011587550.000 Why?
Case-Control Studies11997220220.000 Why?
Adolescent12005878190.000 Why?
DiPiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (192)
Explore
_
Co-Authors (63)
Explore
_
Similar People (58)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.